GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Debt-to-EBITDA

HLB Science (XKRX:343090) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

HLB Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. HLB Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. HLB Science's annualized EBITDA for the quarter that ended in . 20 was ₩0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for HLB Science's Debt-to-EBITDA or its related term are showing as below:

XKRX:343090's Debt-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 1.43
* Ranked among companies with meaningful Debt-to-EBITDA only.

HLB Science Debt-to-EBITDA Historical Data

The historical data trend for HLB Science's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Debt-to-EBITDA Chart

HLB Science Annual Data
Trend Dec22 Dec23
Debt-to-EBITDA
-2.07 -0.70

HLB Science Quarterly Data
Debt-to-EBITDA

Competitive Comparison of HLB Science's Debt-to-EBITDA

For the Biotechnology subindustry, HLB Science's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Science's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HLB Science's Debt-to-EBITDA falls into.



HLB Science Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

HLB Science's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(104.186 + 1004.794) / -1591.005
=-0.70

HLB Science's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (. 20) EBITDA data.


HLB Science  (XKRX:343090) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


HLB Science Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HLB Science's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines